N- [(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methy l]-benzamide derivatives, preparation thereof, and therapeutic use thereof

Details for Australian Patent Application No. 2010212703 (hide)

Owner Sanofi

Inventors Dargazanli, Gihad; Estenne-Bouhtou, Genevieve; Medaisko, Florence

Agent A J Park

Pub. Number AU-A-2010212703

PCT Pub. Number WO2010/092287

Priority 09/00579 10.02.09 FR

Filing date 9 February 2010

Wipo publication date 19 August 2010

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/092287 Priority application(s): WO2010/092287

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212704-Substituted 3-benzofuranyl-indol-2-one-3-acetamid opiperazine derivatives, preparation thereof, and therapeutic use thereof

2010212702-N- [(2-azabicyclo[2.1.1]hex-1-yl]-aryl-meth yl]-benzamide derivatives, preparation thereof, and therapeutic use thereof